Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants

QJM: An International Journal of Medicine

Volumn 96, Issue 5, 2003, Pages 369-374

  Whyte, I M ^a,b   Dawson, A H ^a,b   Buckley, N A ^c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORAL HYDRATE; CONVULSANT AGENT; DOSULEPIN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CARDIOTOXICITY; COHORT ANALYSIS; COMA; CONTROLLED STUDY; DEATH; DRUG OVERDOSE; FEMALE; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE; SELF POISONING; SUICIDE;

EID: 0037598812     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hcg062     Document Type: Article

References (30)

1. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986; 35:4493-7.
2. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants [published erratum appears in Br Med J 1995 Apr 8; 310(6984):911]. Br Med J 1995; 310:221-4.
3. Beerworth EE, Tiller JW. Liability in prescribing choice: the example of the antidepressants. Aust N Z J Psychiatry 1998; 32:560-6.
4. Freemantle N, House A, Song F, Mason JM, Sheldon TA. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. Br Med J 1994; 309:249-53.
5. Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. Br Med J 2002; 325:1332-3.
6. Rudolph RL, Derivan AT, Khan A. The safety and tolerability of venlafaxine hydrochloride: Analysis of the clinical trials database. J Clin Psychopharmacol 1996; 16:54-61S.
7. Peano C, Leikin JB, Hanashiro PK. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med 1997; 30:704-8.
8. Durback LF, Scharman EJ. Comment: seizure resulting from venlafaxine overdose. Ann Pharmacother 1997; 31:790-1.
9. White CM, Gailey RA, Levin GM, Smith T. Seizure resulting from a venlafaxine overdose. Ann Pharmacother 1997; 31:178-80.
10. Zhalkovsky B, Walker D, Bourgeois JA. Seizure activity and enzyme elevations after venlafaxine overdose. J Clin Psychopharmacol 1997; 17:490-1.
11. Leaf EV. Comment: Venlafaxine overdose and seizure. Ann Pharmacother 1998; 32:135-6.
12. Coorey AN, Wenck DJ. Venlafaxine overdose. Med J Aust 1998; 168:523.
13. Blythe D, Hackett LP. Cardiovascular and neurological toxicity of venlafaxine. Hum Exp Toxicol 1999; 18:309-13.
14. Jaffe PD, Batziris HP, Van der Hoeven P, DeSilva D, McIntyre IM. A study involving venlafaxine overdoses: Comparison of fatal and therapeutic concentrations in postmortem specimens. J Forensic Sci 1999; 44:193-6.
15. Parsons AT, Anthony RM, Meeker JE. Two fatal cases of venlafaxine poisoning. J Anal Toxicol 1996; 20:266-8.
16. Colbridge MG, Volans GN. Venlafaxine in overdose - experience of the national poisons information service (London centre). EAPCCT XIX International Congress abstract. J Toxicol Clin Toxicol 1999; 37:383.
17. Buckley NA, Dawson AH, Whyte IM, Henry DA. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet 1994; 343:159-62.
18. Buckley NA, Whyte IM, Dawson AH, McManus PR, Ferguson NW. Self-poisoning in Newcastle, 1987-1992. Med J Aust 1995; 162:190-3.
19. Buckley NA, Whyte IM, Dawson AH, Reith DA. Preformatted admission charts for poisoning admissions facilitate clinical assessment and research. Ann Emerg Med 1999; 34:476-82.
20. Whyte IM, Buckley NA, Dawson AH. Data collection in clinical toxicology: are there too many variables? J Toxicol Clin Toxicol 2002; 40:223-30.
21. Buckley NA, Whyte IM, Dawson AH. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol 1995; 33:199-204.
22. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs, 1999. Oslo, WHO, 1999.
23. Boehnert M, Lovejoy F. QRS duration in acute overdose of tricyclic antidepressants. N Engl J Med 1986:988-90.
24. Bazett H. An analysis of the time-relations of electrocardiograms. Heart 1920; 7:353-70.
25. Plum F, Posner JB. The diagnosis of stupor and coma. Contemp Neurol Ser 1972; 10:1-286.
26. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148:705-13.
27. Dunn OJ. Multiple comparisons using rank sums. Technometrics 1964; 6:241-52.
28. Khalifa M, Daleau P, Turgeon J. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999; 291:280-4.
29. Lessard E, Yessine MA, Hamelin BA, Gauvin C, Labbe L, O'Hara G, LeBlanc J, Turgeon J. Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans. J Clin Psychopharmacol 2001; 21:175-84.
30. Lessard E, Yessine MA, Hamelin BA, O'Hara G, LeBlanc J, Turgeon J. Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans. Pharmacogenetics 1999; 9:435-43.